| Typicality: | 0.429 |
| Saliency: | 0.420 |
| with disease progression | 7 | other |
| after platinum-containing chemotherapy | 6 | temporal |
| tumor → be determined by → fda-approved test | 27 |
| tumor → be detected by → fda-approved test | 13 |
| negative | neutral | positive |
| 0.089 | 0.797 | 0.114 |
| Raw frequency | 40 |
| Normalized frequency | 0.420 |
| Modifier score | 0.500 |
| Perplexity | 110.898 |